New York–based Synchron built its BCI technology on the Nvidia Holoscan platform. It says the collaboration could redefine the possibilities of real-time neural interaction and intelligent edge processing.
Holoscan offers a unified framework that supports diverse AI models and data modalities. It also features an optimized application framework, with seamless sensor I/O integration, GPU-direct data ingestion, accelerated computing and real-time AI.
The collaboration leverages Holoscan to advance a next-generation BCI in two domains. First, Synchron wants to enhance real-time edge AI capabilities for on-device neural processing. This could improve signal processing and multi-AI inference technology, reducing system latency and bolstering privacy. Altogether, it creates a more responsive, intuitive BCI experience.
Synchron said the second domain comes in the form of exploring the development of a groundbreaking foundation model for brain inference. By processing its neural data on an unprecedented scale, the company says the initiative could create scalable, interpretable brain-language models. This could potentially transform neuroprosthetics, cognitive expression and seamless interaction with digital devices.
“Synchron’s vision is to scale neurotechnology to empower humans to connect to the world, and the NVIDIA Holoscan platform provides the ideal foundation,” said Tom Oxley, M.D., Ph.D., CEO & Founder, Synchron. “Together, we’re setting a new benchmark for what BCIs can achieve.”
More about Synchron and Nvidia
Synchron’s BCI system is stent-based and uniquely delivered through an endovascular approach. It taps into blood vessels to capture signals from the brain. It could restore the capability for severely paralyzed patients to control personal devices with hands-free point-and-click. The company could be the leader in a growing BCI space with a massive market opportunity.
The Synchron BCI offers an alternative to the open-brain surgery method used by BCI rival Neuralink. Synchron delivers its nitinol Stentrode implant with a catheter via the jugular and through the brain’s transverse sinus to the superior sagittal sinus for placement. The median deployment time in the study was 20 minutes.
Nvidia, meanwhile, is a leader in AI computing and has worked with a number of medtech companies to incorporate AI into their technologies. Johnson & Johnson MedTech announced last year that it plans to accelerate and scale AI for surgery in partnership with Nvidia. GE HealthCare and Nvidia partnered to bring AI to ultrasound technology in March 2024 as well.
Asensus Surgical linked up with Nvidia in 2023 to deliver novel clinical intelligence to surgeons in surgical robotics. Medtronic also partnered with Nvidia to enable an AI Access platform to boost the GI Genius intelligent endoscopy module’s capabilities.
